Legend Biotech Corporation (NASDAQ:LEGN) is one of the best US stocks to buy under $50. On January 15, analysts at Deutsche Bank reiterated a Buy rating on Legend Biotech Corporation (NASDAQ:LEGN) and set a$60 price target. The positive stance comes amid expectations that the company will deliver topline results from its first in-vivo CAR T program for patients before the end of the year. Deutsche Bank and Cantor Fitzgerald Bullish on Legend Biotech (LEGN) on Oncology Pipeline Development Photo by Toon ...